|
Vaccine Detail
Inactivated split Mem 71 Virus with SPT adjuvant |
Vaccine Information |
- Vaccine Name: Inactivated split Mem 71 Virus with SPT adjuvant
- Target Pathogen: Influenza virus
- Target Disease: Influenza (flu)
- Vaccine Ontology ID: VO_0004244
- Type: Inactivated or "killed" vaccine
- Status: Research
- Antigen: Inactivated Mem 71virus (A/Memphis/l/71 x A/Bellamy/42 (H3N1) recombinant) (Deliyannis et al., 1998).
- Adjuvant:
- Immunization Route: subcutaneous injection
|
Host Response |
Mouse Response
- Host Strain: BALB/c
- Vaccination Protocol: Mice were immunized subcutaneously on day 0 with 0.1 ml of vaccine containing various doses of split Mem 71 virus with or without adjuvant (Deliyannis et al., 1998).
- Challenge Protocol: MIce were challenged intranasally with 10^4.5 plaque forming units (p.f.u.) of live Mem 71 influenza virus (Deliyannis et al., 1998).
- Efficacy: Protection from subsequent influenza infection was assessed by examining the ability of vaccinated mice to clear a challenge dose of virus from their lungs by 3 days postinfection. Mice immunized with virus in SPT adjuvant had greater levels of viral clearance than in mice immunized without adjuvant (Deliyannis et al., 1998).
|
References |
Deliyannis et al., 1998: Deliyannis G, Jackson DC, Dyer W, Bates J, Coulter A, Harling-McNabb L, Brown LE. Immunopotentiation of humoral and cellular responses to inactivated influenza vaccines by two different adjuvants with potential for human use. Vaccine. 1998; 16(20); 2058-2068. [PubMed: 9796065].
|
|